reactive arthritis: Reactive arthritis (ReA) is an autoimmune disorder belonging to the group of seronegative spondyloarthropathies and is characterized by the classic triad of arthritis, urethritis and conjunctivitis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3489 |
4. Check minimum number of eventsNone |
3489 |
5. Include endpointsNone |
3489 |
6. Filter based on genotype QC (FinnGen only) |
3384 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Reactive arthropathies based on the number of shared cases.
Similar with more cases:
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 28731 | 13789 | 14752 |
Only index persons | 25824 | 12637 | 13187 |
Unadjusted period prevalence (%) | |||
Whole population | 0.40 | 0.39 | 0.41 |
Only index persons | 0.48 | 0.46 | 0.50 |
Median age at first event (years) | |||
Whole population | 41.97 | 43.22 | 40.67 |
Only index persons | 40.95 | 42.21 | 39.74 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 3384 | 1864 | 1520 |
Unadjusted period prevalence (%) | 0.75 | 0.73 | 0.76 |
Median age at first event (years) | 43.67 | 41.98 | 45.73 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint M13_REACTARTH and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
M13_REACTARTH | 1.224 [1.1, 1.37] | < 0.001 |
Birth year | 0.994 [0.99, 1.0] | 0.135 |
During the follow-up period (1.1.1998 — 31.12.2019), 1005 out of 9191 females with M13_REACTARTH died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
M13_REACTARTH | 1.254 [1.13, 1.39] | < 0.001 |
Birth year | 0.99 [0.98, 1.0] | 0.031 |
During the follow-up period (1.1.1998 — 31.12.2019), 1365 out of 9460 males with M13_REACTARTH died.
Mortality risk
Mortality risk for people of age
years, who have M13_REACTARTH.N-year risk | Females | Males |
---|---|---|
1 | 0.138% | 0.251% |
5 | 0.681% | 1.546% |
10 | 1.727% | 4.137% |
15 | 3.457% | 7.852% |
20 | 5.882% | 13.56% |
Relationships between endpoints
↥Index endpoint: M13_REACTARTH – Reactive arthropathies
GWS hits: 1